The AAOS Advocacy Podcast covers the latest health policy issues affecting musculoskeletal health. Each episode features expert insights on the changing landscape of orthopaedics and advocacy efforts to advance quality and access to care. Part of “The Bone Beat” orthopaedic podcast channel.
Language
🇺🇲
Publishing Since
2/27/2020
Email Addresses
1 available
Phone Numbers
0 available
September 9, 2024
The American Academy of Orthopaedic Surgeons (AAOS) recently went through a comprehensive multi-year process to re-imagine its core focus and aspirational state to be the trusted leaders in advancing musculoskeletal health. Members of the AAOS Presidential Line provide behind-the-scenes perspective that explores the need for change, and how these changes provide a foundation for greater collaboration, innovation, learning opportunities and benefits for current and future members, patients and the larger musculoskeletal community. More on AAOS’ proposed governance changes: https://www.aaos.org/about/meet-aaos/proposed-governance-changes/ Moving Forward: AAOS Board of Directors Approves New Strategic Plan, (AAOS Now, April 2024): https://www.aaos.org/aaosnow/2024/march-april/commentary/commentary01/ Look Towards the Future, (AAOS Now, August 2024), https://www.aaos.org/aaosnow/2024/aug/youraaos/youraaos01 Host: Valerae O. Lewis, MD, FAAOS, AAOS Membership Council Chair Guests: Paul Tornetta III, MD, PhD, FAAOS, AAOS President Annunziato (Ned) Amendola, MD, FAAOS, AAOS First Vice President Joel Mayerson, MD, FAAOS, FAOA, AAOS Board of Councilors Chair
May 29, 2024
This episode covers an array of topics related to increasing consolidation within the healthcare system, from banning non-competes to tightening cybersecurity. OrthoForum CEO Karen Simonton offers her perspective and wealth of knowledge, having worked with orthopaedic groups over the last decade, on how this changing landscape is impacting private practices and their ability to provide care. Host: Adam Bruggeman, MD, FAAOS, FAOrthA, Chair, AAOS Advocacy Council Guest: Karen Simonton, CEO, OrthoForum
March 13, 2024
Comedian and ophthalmologist Dr. Will Flanary, better known as Dr. Glaucomflecken by his 4 million followers on social media, recently sat down for an exclusive interview during the AAOS 2024 Annual Meeting. He shared his story of going from patient to accidental healthcare advocate and explained how he uses medical satire to entertain and bring attention to key public policy issues. Guest: Will Flanary, MD, AKA Dr. Glaucomflecken, comedian and ophthalmologist Host: Adam Bruggeman, MD, FAAOS, FAOrthA, Chair, AAOS Advocacy Council More links to Dr. Glaucomflecken: YouTube Website Twitter TikTok Instagram
Dr. Jim Dahle of the White Coat Investor
NPR
American Academy of Orthopaedic Surgeons
The Wall Street Journal & Gimlet
Peter Attia, MD
The New York Times
Ben Gilbert and David Rosenthal
TED
NPR
Vox Media Podcast Network
The Wall Street Journal
Mohit Bhandari and Marc Swiontkowski
The New York Times
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.